Copyright
©The Author(s) 2018.
World J Gastrointest Oncol. Dec 15, 2018; 10(12): 496-504
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.496
Published online Dec 15, 2018. doi: 10.4251/wjgo.v10.i12.496
Hazard ratio | 95%CI | P value | |
Pathogenesis | 1.227 | 0.773–1.948 | 0.385 |
Albumin (g/L) | 1.266 | 0.829–1.932 | 0.275 |
Alanine aminotransferase (U/L) | 1.222 | 0.798–1.872 | 0.357 |
Glutamyl transpeptidase (U/L) | 0.821 | 0.509–1.224 | 0.419 |
Direct bilirubin (μmol/L) | 2.262 | 0.270–18.96 | 0.452 |
Aspartate aminotransferase (U/L) | 1.270 | 0.800–2.017 | 0.311 |
No. of liver tumors | 1.238 | 0.232–19.41 | 0.330 |
- Citation: Wu YF, Wang T, Yue ZD, Zhao HW, Wang L, Fan ZH, He FL, Liu FQ. Stents combined with iodine-125 implantation to treat main portal vein tumor thrombus. World J Gastrointest Oncol 2018; 10(12): 496-504
- URL: https://www.wjgnet.com/1948-5204/full/v10/i12/496.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v10.i12.496